Sequencing-based methods for mapping DNA double-strand breaks (DSBs) allow 26 measurement only of relative frequencies of DSBs between loci, which limits our 27 understanding of the physiological relevance of detected DSBs. We propose quantitative 28 DSB sequencing (qDSB-Seq), a method providing both DSB frequencies per cell and their 29 precise genomic coordinates. We induced spike-in DSBs by a site-specific endonuclease 30
Introduction 39
There is tremendous interest in precisely measuring DNA double-strand breaks (DSBs) 40 genome-wide since such measurement can give key insights into DNA damage and repair, 41 cancer development 1 , radiation biology, and also increasingly popular genome editing 42 techniques 2 . Starting with our BLESS method 3 , several high-resolution and direct methods 43 to label DSBs genome-wide have recently been developed 4-7 , which have opened up new 44 possibilities for sensitive and specific detection of DSBs. For example, BLESS was applied 45 in identifying the on-target and off-target cutting sites of Cas9 endonuclease 8 and studying 46 DSB repair 9 . However, we still lack an effective strategy to both precisely detect DSB 47 distribution genome-wide and quantify their absolute frequencies per cell, which is crucial 48
to assess physiological relevance of detected DSBs. Immunofluorescence microscopy in 49 combination with γ-H2AX and 53BP1 antibodies was used to count breaks per cell 10 , but 50
does not allow determining their precise locations. Moreover, counting discrete nuclear 51
foci is an imprecise way to estimate DSB numbers per cell both due to DSB clustering and 52 limited specificity of antibodies. Quantitative Polymerase Chain Reaction (qPCR) based 53 methods can estimate absolute break frequency but only at selected loci 11 . An approach 54
was developed recently to quantify breaks globally based on amount of radiolabeled DNA 55 and locally based on DNA break immunocapture 12 , but its accuracy in detecting 56
physiological DSBs was not tested. BLISS 7 quantifies DSBs by utilizing unique molecular 57 identifiers (UMIs) to identify unique DSB ends and counting cells in the sample. BLISS is 58 designed for detecting DSBs in samples with low number of cells and thus shares 59 challenges of single-cell sequencing, such as low genome coverage and over-amplification. 60 Moreover, employment of UMIs is challenging. Short UMIs may lead to UMI collisions 13 61 (i.e. observing two reads with the same sequence and the same UMI barcode but originating 62 from two different genomic molecules), especially in case of DSBs enriched in specific 63
locations. Long UMIs may interfere with primer sequence binding and accumulate 64 sequencing errors, which may lead to severe overestimation of DSBs 14 . 65
This lack of a general method and computational solution to simultaneously determine 66 DSB frequencies per cell and their precise genomic loci limits our understanding of the 67 physiological relevance of observed DSBs and hinders comparisons between experiments. 68 Here, we propose quantitative DSB sequencing (qDSB-Seq), an approach that allows 69 measuring DSB frequencies per cell genome-wide, and a computational solution to achieve 70 accurate quantification. Our approach relies on inducing spike-in DSBs by a site-specific 71 endonuclease, which are used to quantify DSBs detected by a DSB labeling method e.g. i-72 BLESS 15 and can be combined with any DSB labeling technique. We present a 73 comprehensive validation and several applications of qDSB-Seq: quantifying DSBs 74 induced by a radiomimetic drug, occurring during replication stress and caused by natural 75 replication fork barriers. 76
77
Results 78 qDSB-Seq implementation, computational method and validation. qDSB-Seq is a 79 combination of genome-wide high-resolution DSB-labeling (i-BLESS 15 , BLESS 3 , END-80 seq 6 , etc.) and inducing DSBs (spike-ins) in pre-determined loci using a site-specific 81 endonuclease ( Fig. 1a-c) . Quantification is based on an assumption (verified below) that 82 the number of labeled reads at a given genomic locus resulting from DSB sequencing is 83
proportional to the underlying DSB frequency (proportionality coefficient α in Fig. 2a ). 84
To estimate this coefficient α, we induce spike-in DSBs at pre-determined genomic loci 85 and, relying on knowledge of their exact genomic locations, quantify their frequency using 86 genomic DNA sequencing (gDNA) or qPCR ( Fig. 1a, Fig. 2a ). The spike-in DSBs are 87 created by digestion with a restriction endonuclease before DSB labeling ( Fig. 1b,c) . Next,  88 the frequency of induced spike-in DSBs, B cut , is calculated from enzyme cutting efficiency, 89 f cut , that is calculated from gDNA sequencing data based on numbers of cut and uncut DNA 90 fragments covering cutting sites in gDNA ( Fig. 2a, Methods) , or qPCR data 91 ( Supplementary Fig. 1, Methods) . 92
Finally, the absolute frequency of studied DSBs, B studied , is estimated from DSB sequencing 93 data: 94 we propose to use gDNA sequencing to determine spike-in cutting efficiencies ( Fig. 2a,  104 Methods). To verify the accuracy and reproducibility of our proposed approach, we treated 105 immobilized and deproteinized yeast DNA with NotI enzyme and compared cutting 106 efficiencies at its recognition sites calculated using gDNA sequencing data and qPCR. The 107
cutting efficiencies for the selected NotI cutting site were highly consistent: 61% for gDNA 108 sequencing and 62% for qPCR. To examine if our approach can also be applied to breaks 109 introduced in vivo, which can be subjected to repair and resection, we used a yeast strain 110 engineered to produce a single site-specific DSB by I-SceI endonuclease in vivo. Cutting 111 efficiencies calculated based on gDNA sequencing and based on qPCR (Supplementary 112 Fig. 1 , Methods) were again very consistent: 71% and 73%, respectively ( Fig. 2b) . We 113 therefore conclude that our method of estimating enzymes cutting efficiency based on 114 gDNA sequencing yields accurate and precise results. 115
Dependence of quantification on enzyme choice and types of breaks induced. DSBs 116
occurring in vivo are subject to DNA damage repair and therefore might be labeled with 117 different efficiencies than breaks induced in vitro. Moreover, different types of double-118 stranded DNA ends (blunt or sticky) could also be detected more or less efficiently by a 119
given DSB labeling method. We therefore asked whether any restriction enzyme and any 120 manner of digestion can be applied to create spike-in DSBs that would lead to accurate 121 quantification. First, to test if restriction enzyme choice or the types of double-stranded 122 DNA ends influences our quantification results, we determined the spontaneous DSB 123 frequencies in yeast G 1 phase cells using NotI or SrfI spike-ins, which create sticky and 124 blunt ends, respectively. The number of spontaneous breaks in G 1 phase cells estimated 125 using these enzymes was consistent: 0.9 ± 0.3 DSBs per cell for NotI spike-in and 1.0 ± 126 0.6 DSBs per cell for SrfI spike-in ( Fig. 2c) . Then, to test if the results are affected by the 127 manner of digestion, we compared DSB estimations based on quantification using NotI (5' 128 overhangs) in vitro digestion and I-SceI (3' overhangs) in vivo digestion in HU-treated 129 wild-type cells (described below). Again, results were highly similar: 137 ± 12 and 153 130 ± 52 DSBs per cell ( Fig. 2d) . In conclusion, qDSB-Seq provided consistent results in all 131 tested cases irrespective of the restriction enzyme used, types of DNA ends created by that 132 enzyme, or the manner of digestion. 133
Dependence of accurate quantification on adequate cutting efficiency. For accurate 134 quantification of studied DSBs, it is necessary that the relationship between the number of 135 labeled reads and DSB frequencies at different genomic locations is linear (Equation (1) , 136 Fig. 2a ). This relationship could be affected by the frequencies of spike-in DSBs, which is 137 determined by an enzyme cutting efficiency. Therefore, we asked whether any frequency 138 of induced spike-in DSBs (i.e. any enzyme cutting efficiency) can be employed. To test 139 the influence of enzyme cutting efficiency on the quantification results, we performed 35 140 digestions for 25 samples using enzymes with multiple cutting sites (NotI, SrfI, AsiSI, and 141
BamHI) and then tested the linear relationship between the labeled reads and cutting 142 efficiencies for each digestion using Pearson Correlation Coefficient. We observed that 143 strong correlation (R > 0.5) (e.g. Fig. 2e ) was always achieved for cutting efficiencies 144 between 12% and 62% ( Supplementary Fig. 2 , Supplementary Table 2 ) and for some 145 lower cutting efficiencies (4-12%). However, for the extreme cutting efficiencies (higher 146 than 84% or lower than 4%) the correlation was always weak (Supplementary Fig. 3) . In 147 such cases, the number of observed cut or uncut fragments was low, making our estimates 148 less accurate, which likely decreased the correlation. Moreover, small variations in f cut 149 between sites contributed to the decreased correlation ( Supplementary Fig. 3 ). 150
Additionally, in samples for which digestion efficiencies are very high, the elevated level 151 of reads at spike-in sites (> 75%) ( Supplementary Table 1 ) can potentially disrupt (due 152 to low initial sequence diversity) Illumina sequencing 16 . Taken together, we conclude that 153 adequate cutting frequencies (4% to 84%) lead to a constant ratio between the labeled reads 154 and the cutting efficiencies for accurate quantification. 155
Stability of estimation of DSB frequencies per cell. We next asked whether our method 156 generates reproducible results. To test this, we calculated DSB frequencies in untreated G 1 157 cells based on different spike-ins. In spite of the various enzymes used (NotI, SrfI) we 158 obtained a very consistent number of DSBs ( Fig. 2f, Supplementary Fig. 4 , 159
Supplementary Table 1 ). Based on our calculations the frequency of spontaneous DSBs 160 in untreated G 1 wild-type cells is 1.0 ± 0.4 DSBs per cell, both the average and the range 161 (0.6-1.7 DSBs per cell) are consistent with previous studies 17, 18 (Supplementary Table  162 1). Further, we quantified DSBs based on the individual cutting sites in each of these 163 samples. The variation of the DSB quantification results depending on the individual 164 cutting sites used was lower than the average value ( Supplementary Table 1 Fig. 4, Supplementary Table 1 ). 169
Applications of qDSB-Seq 170
Quantification of DSBs induced by a radiomimetic drug, Zeocin. Some DSB-inducing 171 agents affect only particular sequences and structures, while others cause DNA damage 172 throughout the genome, e.g. irradiation. As DSB sequencing data inform only about read 173 distribution in the genome and is primarily used to identify regions enriched in reads, even 174 very large but global DSB induction will be undetectable using typical normalization 175 methods, e.g. normalization to the background. Therefore, to test application of qDSB-Seq 176
to such a challenging case, we used the radiomimetic agent Zeocin 19 , a member of the 177 bleomycin drug family. After performing DSB sequencing, no apparent difference in raw 178 read counts between Zeocin-treated (ZEO) and untreated G 1 phase (G 1 ) cells was observed 179 ( Fig. 3a, Supplementary Fig. 5 ). In contrast, after quantification (using qDSB-Seq with 180
NotI spike-in) we concluded that 1. treated sample occur 1.8 times as often between predicted nucleosome positions 20 as within 188 nucleosomes ( Fig. 3b) . Moreover, the preference for DSB location between nucleosomes 189 is even higher (4.1-fold) for long (> 100 nt) NDR regions ( Fig. 3c,d The detected breaks showed a clear replication-related pattern: a significant enrichment of 210 DSB signal around replication origins (Fig. 4b,c) . To further analyze the HU-induced 211
DSBs we classified them into two-ended DSBs and one-ended DSBs (Supplementary Fig.  212  6) . Two-ended DSBs arise when two strands of DNA double helix are damaged (by i.e. 213 endonucleases, radiation or chemical compounds), while broken replication forks result in 214 one-ended DSBs. We identified one-ended DSBs using our method based on comparing 215
the number of reads between Watson and Crick strands ( Supplementary Fig. 6 , Methods) 216
and discovered that among all DSBs detected in HU-treated WT cells 71.7 ± 6.2 DSBs 217
were one-ended ( Fig. 4d) . Of those, 85% (60.6 ± 5.2 DSBs) were located within +/-10 kb 218 regions of active origins, resulting in an average of 0.4 one-ended DSB (broken fork) per 219 origin (Fig. 4d) . Such one-ended DSBs would not be detected by some other DSB detecting 220 methods, such as pulse-field gel electrophoresis, which explains some earlier reports that 221 wild-type yeast cells are not sensitive to HU 25 . The observed one-ended DSBs might  222  correspond to broken forks resulting from transient DNA breaks occurring on the leading  223 strand, as reported by Sasaki et al 26 . In agreement with this theory, we discovered that two 224 hours after removal of HU, the number of one-ended DSBs decreased dramatically (by 225 86%) ( Fig. 4d) , indicating that replication-associated DNA damage present during HU 226 treatment is not permanent. 227
Quantification of DSBs at ribosomal replication fork barriers. Replication fork barriers 228 (RFBs) are natural barrier that blocks replication forks to protect nearby, highly expressed 229 rRNA genes from collisions between transcription and replication complexes 26, 27 (Fig. 5a) . 230 DSBs occurring at the ribosomal replication fork barriers (RFBs) have been observed using 231
Southern blot in the budding yeast [28] [29] [30] [31] . However, precise frequencies and genomic 232 locations of these DSBs were not established due to lack of a quantitative and sensitive 233 DSB detection method 26 . Using qDSB-Seq, here we both precisely quantified DSB 234 frequencies near RFBs and identified their genomic coordinates. 235
It was reported that Fob1 proteins bound to an RFB site block replication fork progression, 236
resulting in generation of a one-ended DSBs 30 . Indeed, in unperturbed S-phase cells, we 237 observed 1.1 DSBs per cell (0.0055 DSBs per rDNA repeat) on rDSB-1 and rDSB-2 sites 238 upstream of RFB1 and RFB2 (two closely spaced RFB loci) (Fig. 5b,c and  239 Supplementary Table 3 ). As expected, we did not detect any DSBs at these sites in G 1 -240 arrested cells confirming that the observed DSBs at RFBs are replication-dependent. 241
It was previously shown that Top1 in the presence of Fob1 specifically cleaves defined 242 sequences in the RFB region 32 . When we inhibited the religation step of Top1 by adding 243 100 µM camptothecin (CPT) for 45 min treatment, we observed a CPT-dependent DSB 244 site (rDSB-3), exactly at the same location as the previously identified Top1-dependent 245 cleavage site (Fig. 5c ). In addition, this site also colocalizes with a Fob1 binding region, in 246 agreement with a previous discovery that the recruitment and stabilization of Top1 requires 247 the binding of Fob1 protein 32 . Our quantification shows the DSB frequency at rDSB-3 site 248 was 0.1 DSB per cell, lower than at rDSB-1 and rDSB-2. Finally, our results agree with 249 previous work 26 in which approximately one DSB arises in an rDNA array during 250 replication in a yeast cell (Fig. 5b) ; such low frequencies are caused by recombination in 251 the rDNA array 26 . Based on the results above, qDSB-Seq fills the need to enable detection 252 of these rare breaks at replication fork barriers and allowed us for the first time to quantify 253 the frequency of cleavage of Topoisomerase 1 (Top1) at RFBs. 254
Discussion 255
We propose qDSB-Seq, a general framework that allows estimating both absolute DSB 256 frequencies (per cell) and their precise genomic coordinates. irradiation or radiomimetic drugs, data normalized to the total reads number will not reveal 269 global induction of breaks as shown in Fig. 3a . In contrast, our approach allows not only 270 estimation of relative increases of DSB signal between samples (regardless of signal 271 distribution), but also quantification of absolute DSB numbers per cell. For example, we 272 discovered that 1 hour treatment with 100 µg/ml Zeocin results in 6.7-times increase in 273
DSBs, namely from 1.1 ± 0.3 to 7.4 ± 1.7 DSBs per cell. Additionally, we discovered that 274
Zeocin significantly increases DSB levels in 99.8% of 5kb genomic intervals, but with 275 differences in ratios: from 1.7-to 13-fold. qDSB-Seq opens up new possibilities in studying 276 the impact of DSB inductors or gene mutations on genome instability, i.e. it may potentially 277 allow determining the outcomes of different doses of anticancer drugs in healthy and tumor 278 cells. Moreover, qDSB-Seq allows assessing DSB frequencies not only for the whole 279 genome, but also for a specific locus. For instance, using our approach, for the first time 280
we quantified changes of DSB frequency at RFBs between wild-type and CPT-treated cells, 281 thus revealing the frequency of Top1-dependent DSBs in RFB region. 282
Key innovation of qDSB-Seq is spike-in DSBs used for normalization. Such spike-in DSBs 283
can be introduced both in vivo and in vitro; each manner of digestion has its strengths and 284
weaknesses. In vivo digestion requires organism-specific constructs, such as the I-SceI 285 yeast strain we used, while in vitro digestion can be applied to any organism. Moreover, 286
for in vitro digestion, since spike-in DSBs are never repaired and thus there are no resected 287 DNA ends. Resected DNA ends may result in spike-in related reads located up to several 288 kilobases from the cutting sites, which may complicate data analysis. On the other hand, 289
for in vivo digestion it is possible to determine enzyme cutting frequency before addition 290 of spike-in cells to the sample of interest, which facilitates obtaining final cutting efficiency 291 in the desired range by selecting desired mixing proportions. In vivo digestion can be also 292 used to study the DNA damage response in systems such as DivA 34 . 293
Enzyme cutting efficiency is a key parameter influencing qDSB-Seq accuracy. As shown 294 above, using extremely low or high cutting efficiencies may result in inaccurate 295 quantification results, while within an adequate range (4% to 84%), the number of labeled 296 reads per DSB (proportionality coefficient α) remains constant, which allows for 297 consistently accurate quantification. If spike-in DSBs are introduced in vivo, to achieve 298 desired cutting efficiency one needs to mix in appropriate proportions cells in which full 299 digestion (or digestion with known efficiency) was performed with the studied cells. In 300 case of in vitro digestion, the studied cells should be treated with a dose of an enzyme much 301 lower than recommended for full digestion. The enzyme cutting efficiency can be then 302 estimated by performing qPCR and, if needed, the dose can be adjusted before sequencing. 303
To facilitate choice of a restriction enzyme for qDSB-Seq experiments we provide lists of 304 restriction enzymes sorted according to their cutting efficiencies per Mb in the yeast, 305
human, mouse and fruit fly genomes (Supplementary Table 4) , as well as Genome-wide 306
Restriction Enzyme Digestion STatistical Analysis Tool, GREDSTAT, at 307 http://bioputer.mimuw.edu.pl:23456. Enzymes with multiple cutting sites should yield best 308 quantification results, since estimation of the enzyme cutting frequency will be less 309 influenced by a potential local bias. Constructs with a single enzyme cutting site, such as 310 the I-SceI strain we employed, allow convenience of using qPCR to determine an enzyme 311 cutting frequency. Therefore, for enzymes with multiple cutting sites, we developed a 312 method to estimate enzyme cutting efficiency from gDNA sequencing data, and proved its 313 accuracy by comparing with qPCR results. On the other hand, usage of rare cutting 314 enzymes is preferable, since they allow for optimal cutting efficiencies at individual sites 315 without unnecessarily increasing percentage of spike-ins in total reads. There is no benefit 316 to using a higher spike-in percentage than necessary; high spike-in percentages, especially 317 exceeding 30-50% of total reads, may cause quality issues with Illumina sequencing 16 . 318
Unlike enzyme cutting efficiency, percentage of spike-in reads cannot be determined 319 before sequencing, since it depends both on enzyme cutting efficiency and number of DSBs 320 present in the data. Therefore, if there is a probability that high level of spike-ins may be 321 achieved unintentionally (e.g. during pilot experiments), we recommend using our 322 modified protocols for generation of high-quality sequencing data from low-diversity 323 samples 16 . 324 qDSB-Seq is compatible with any DSB labeling technique, but will also share limitations 325 of the used method. For example, we tested that the type of generated DNA ends will not 326 determine quantification results when using i-BLESS for DSB labeling. However, as we 327 discussed in 15 , some DSB sequencing technologies cannot detect all types of DNA ends. 328
Therefore, qDSB-Seq, when used in combination with such technology, will also exhibit 329 bias in quantifying DSBs with these types of DNA ends. 330
When interpreting qDSB-Seq results, it is important to keep in mind that qDSB-Seq relies 331 on sequencing data derived from a population of cells. Therefore, it only yields an average 332 number of DSBs per cell, which may or may not be representative of a typical single cell. 333
This problem can be solved by combining qDSB-Seq with a complementary method, 334
giving insight into population-distribution of DSBs, as we proposed elsewhere 33 . 335
In summary, qDSB-Seq is a novel approach, which allows absolute DSB quantification 336 genome-wide and accurate cross-sample comparison and can be applied to any organism, 337
for which a DSB labeling method is available. qDSB-Seq relies on a key innovation, using 338 spike-in DSBs induced by a restriction enzyme for normalization. Using qDSB-Seq, we 339 quantified the numbers of DSBs induced by a radiomimetic drug and replication stress; 340 measured for the first time Top1-dependent DSB frequencies at replication fork barriers 341
and revealed several orders of magnitude differences in DSB frequencies. Such high 342 variability in genome breakage highlights the importance of quantification and shows how 343 challenging data interpretation would be without the normalization provided by qDSB-Seq. Next, DSBs are labeled (using e.g. i-BLESS) and sequenced. Simultaneously, gDNA sequencing (or qPCR) is performed and used to estimate the cutting efficiency of the enzyme, and thus frequency of induced DSB spike-ins, which is then used to quantify the absolute DSB frequency (per cell) of studied DSBs in the sample (Methods). (b-c) Spikein DSBs were induced in two different ways: (b) the studied cells were digested using the NotI, SrfI, AsiSI, or BamHI restriction enzyme in vitro; (c) cells expressing the restriction enzyme I-SceI in vivo (the I-SceI strain) were mixed with the studied cells. 
